468 related articles for article (PubMed ID: 17556064)
21. Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer.
Zhang X; Miao X; Liang G; Hao B; Wang Y; Tan W; Li Y; Guo Y; He F; Wei Q; Lin D
Cancer Res; 2005 Feb; 65(3):722-6. PubMed ID: 15705867
[TBL] [Abstract][Full Text] [Related]
22. DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia.
Batar B; Güven M; Bariş S; Celkan T; Yildiz I
Leuk Res; 2009 Jun; 33(6):759-63. PubMed ID: 19101034
[TBL] [Abstract][Full Text] [Related]
23. Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer.
Chacko P; Rajan B; Joseph T; Mathew BS; Pillai MR
Breast Cancer Res Treat; 2005 Jan; 89(1):15-21. PubMed ID: 15666192
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk.
De Ruyck K; Szaumkessel M; De Rudder I; Dehoorne A; Vral A; Claes K; Velghe A; Van Meerbeeck J; Thierens H
Mutat Res; 2007 Jul; 631(2):101-10. PubMed ID: 17531525
[TBL] [Abstract][Full Text] [Related]
25. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
[TBL] [Abstract][Full Text] [Related]
26. ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population.
Justenhoven C; Hamann U; Pesch B; Harth V; Rabstein S; Baisch C; Vollmert C; Illig T; Ko YD; Brüning T; Brauch H
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2059-64. PubMed ID: 15598761
[TBL] [Abstract][Full Text] [Related]
27. [DNA repair gene xeroderma pigmentosum group D 751 polymorphism and the risk on esophageal cancer: a meta-analysis].
Wu XB; Dai LP; Wang YP; Wang KJ; Zhang JY
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Mar; 30(3):281-5. PubMed ID: 19642387
[TBL] [Abstract][Full Text] [Related]
28. Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer.
Zhou W; Liu G; Miller DP; Thurston SW; Xu LL; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Res; 2002 Mar; 62(5):1377-81. PubMed ID: 11888908
[TBL] [Abstract][Full Text] [Related]
29. XRCC1 genotype and breast cancer: functional studies and epidemiologic data show interactions between XRCC1 codon 280 His and smoking.
Pachkowski BF; Winkel S; Kubota Y; Swenberg JA; Millikan RC; Nakamura J
Cancer Res; 2006 Mar; 66(5):2860-8. PubMed ID: 16510609
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms of DNA repair genes XRCC1 and XPD and risk of primary open angle glaucoma (POAG).
Güven M; Unal M; Batar B; Eroğlu E; Devarnoğlu K; Tamçelik N; Uçar D; Sarici A
Mol Vis; 2007 Jan; 13():12-7. PubMed ID: 17242676
[TBL] [Abstract][Full Text] [Related]
31. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk.
Stern MC; Johnson LR; Bell DA; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1004-11. PubMed ID: 12376500
[TBL] [Abstract][Full Text] [Related]
32. Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer.
Jeon HS; Kim KM; Park SH; Lee SY; Choi JE; Lee GY; Kam S; Park RW; Kim IS; Kim CH; Jung TH; Park JY
Carcinogenesis; 2003 Oct; 24(10):1677-81. PubMed ID: 12869423
[TBL] [Abstract][Full Text] [Related]
33. Adenosine diphosphate ribosyl transferase and x-ray repair cross-complementing 1 polymorphisms in gastric cardia cancer.
Miao X; Zhang X; Zhang L; Guo Y; Hao B; Tan W; He F; Lin D
Gastroenterology; 2006 Aug; 131(2):420-7. PubMed ID: 16890595
[TBL] [Abstract][Full Text] [Related]
34. XRCC1 and XRCC3 polymorphisms and their role as effect modifiers of unsaturated fatty acids and antioxidant intake on colorectal adenomas risk.
Stern MC; Siegmund KD; Corral R; Haile RW
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):609-15. PubMed ID: 15767338
[TBL] [Abstract][Full Text] [Related]
35. Platelet 12-lipoxygenase Arg261Gln polymorphism: functional characterization and association with risk of esophageal squamous cell carcinoma in combination with COX-2 polymorphisms.
Guo Y; Zhang X; Tan W; Miao X; Sun T; Zhao D; Lin D
Pharmacogenet Genomics; 2007 Mar; 17(3):197-205. PubMed ID: 17460548
[TBL] [Abstract][Full Text] [Related]
36. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures.
Saadat M; Ansari-Lari M
Breast Cancer Res Treat; 2009 May; 115(1):137-44. PubMed ID: 18481169
[TBL] [Abstract][Full Text] [Related]
37. XRCC1 polymorphism and lung cancer risk.
Schneider J; Classen V; Helmig S
Expert Rev Mol Diagn; 2008 Nov; 8(6):761-80. PubMed ID: 18999926
[TBL] [Abstract][Full Text] [Related]
38. Polymorphism in the ERCC2 codon 751 is associated with arsenic-induced premalignant hyperkeratosis and significant chromosome aberrations.
Banerjee M; Sarkar J; Das JK; Mukherjee A; Sarkar AK; Mondal L; Giri AK
Carcinogenesis; 2007 Mar; 28(3):672-6. PubMed ID: 17050553
[TBL] [Abstract][Full Text] [Related]
39. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
[TBL] [Abstract][Full Text] [Related]
40. Association between X-ray repair cross complementing group 1 codon 399 and 194 polymorphisms and lung cancer risk: a meta-analysis.
Wang Y; Yang H; Li H; Li L; Wang H; Liu C; Zheng Y
Cancer Lett; 2009 Nov; 285(2):134-40. PubMed ID: 19481337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
